Leadiant Biosciences, formerly known as Sigma-Tau Industrie Farmaceutiche Riunite, was founded in 1957 by research chemist Claudio Cavazza. In 2018 Leadiant...
16 KB (1,996 words) - 17:51, 11 April 2024
approved by the U.S. Food and Drug Administration (FDA) in 2018. Leadiant Biosciences was awarded a priority review voucher for its development under the...
4 KB (198 words) - 06:17, 30 May 2022
PMID 19322184. S2CID 24486546. "Abelcet Package Insert" (PDF). Leadiant Biosciences. Sigma-Tau Pharmaceuticals. Retrieved 14 July 2022. Mesa-Arango AC...
44 KB (4,077 words) - 22:38, 11 September 2024
Authority for Consumers and Markets in respect of the pricing policy of Leadiant Biosciences Ltd, formerly known as Sigma-Tau Rare Disease, for chenodeoxycholic...
6 KB (656 words) - 16:05, 10 May 2023
GlaxoSmithKline Rare pediatric Revcovi Adenosine deaminase-SCID Leadiant Biosciences Rare pediatric Gamifant Haemophagocytic lymphohistiocytosis Novimmune...
33 KB (3,432 words) - 02:00, 20 March 2024
Plaintiff VSL Pharmaceuticals, Inc. ("VSL"), Defendant Leadiant Biosciences, Inc. ("Leadiant") and Defendant Alfasigma USA, Inc. ("Alfasigma")" (PDF)...
10 KB (1,096 words) - 00:47, 16 September 2023
Cadista KaloCyte KCRN Research Kemp Proteins Key Tech Kolon TissueGene Leadiant Biosciences Leidos Biomedical Research LKC Technologies Longhorn Vaccines Lonza...
30 KB (3,219 words) - 00:46, 16 August 2024
Sigma tau, 07-07-24 Archived 18 April 2012 at the Wayback Machine "Leadiant Biosciences | Dave Lemus promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals...
20 KB (2,046 words) - 10:36, 23 May 2024